Judging by some of the heavy action in the world of biotechnology, one could easily conclude that the industry is going to the dogs. Or cats, maybe.
There are start-ups named Nexvet and VetDC, CanFel Therapeutics (as in canine and feline), and even Fetch Pharma.
It’s a new example of pack behavior: Entrepreneurs with pedigrees from companies like Genentech and Amgen are now turning their attention to pets. They hope to develop innovative drugs for dogs and cats like those that have revolutionized the treatment of diseases like cancer and arthritis in people.
“We’ve been drugging ourselves for a long time and more recently we’ve been drugging our kids,” said Oleg Nodelman, an investor in and director of Kindred Biosciences, one of the new companies. “Why shouldn’t our pets have access to medicine?”
They do already, of course. Many of the big pharmaceutical companies have long had veterinary drug divisions. Eli Lilly’s animal division, Elanco, for instance, sells the company’s Prozac antidepressant under the name Reconcile to treat canine separation anxiety.
But the new entrepreneurs say they will be more nimble and do what the big companies are not doing, just as the early human medicine biotech companies did.
The big companies focus more on livestock — edible animals as opposed to petable ones, said Steven St. Peter, chief executive of Aratana Therapeutics, a pet biotech company. Their offerings for pets are mainly vaccines and treatments for fleas, ticks and worms.
The new companies hope instead to treat diseases like cancer and arthritis. Many are trying to develop monoclonal antibodies, which are proteins made in living cells. Such antibodies, like Humira for rheumatoid arthritis and Herceptin for breast cancer, are huge sellers in human medicine but have had almost no role so far in animal health.
Read more . . .
The Latest on: Biotech Drugs for Pets
[google_news title=”” keyword=”Biotech Drugs for Pets” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Biotech Drugs for Pets
- Lululemon Scion JJ Wilson Plots to Make Psychedelic Drugs the New Yogaon May 12, 2024 at 8:47 pm
Chip Wilson’s son has visions of turning his legal drugs business into a tripped out version of Lululemon’s global yoga apparel empire.
- Recall Sparks Nationwide Warning for Dog Ownerson May 8, 2024 at 2:17 pm
According to the FDA, Palmer Candy was warned by its supplier that it uses for the liquid coating on its white-coated items about the risk of salmonella. The products were sold in stores—including ...
- Biotech CEL-SCI gets FDA go-ahead to conduct investigational cancer immunotherapy studyon May 8, 2024 at 11:18 am
Listen to this article CEL-SCI Corporation, the Vienna, Virginia-based biotechnology company with operations in Baltimore, Wednesday received approval from the U.S. Food and Drug Administration to ...
- Meticulous Market Research Pvt. Ltd.: Pharmaceutical Packaging Market to Be Worth $176.54 Billion by 2031 - Exclusive Report by Meticulous Research®on May 3, 2024 at 7:50 am
According to a new market research report titled, "Pharmaceutical Packaging Market by Material (Polymer [PE, PP, PET], Glass) Type (Bottles, Blister ...
- Pharmaceutical Packaging Market to Be Worth $176.54 Billion by 2031 - Exclusive Report by Meticulous Research®on May 3, 2024 at 3:31 am
Primary pharmaceutical packaging consists of containers and materials that directly contact the drug product or medicine ... The packaging industry is moving toward PET plastic and other ...
- ‘She was family’: Arlington woman says service dog died after pharmacy gave her wrong medicationon May 2, 2024 at 7:50 am
An Arlington woman says her 10-year-old Cavalier King Charles spaniel died after a veterinarian prescribed one medication but a CVS pharmacy dispensed a different drug.
- Carbios breaks ground on ‘world’s first’ PET biorecycling planton April 29, 2024 at 3:08 am
Carbios, a biotech company aiming to transform the life cycle of plastics and textiles, has broken ground on the world's first PET biorecycling plant.
- Zoetis Stock Slumps on Report Suggesting Its Arthritis Drugs May Make Pets Sickon April 12, 2024 at 11:04 am
Zoetis (ZTS) shares tumbled in intraday trading Friday following a Wall Street Journal report suggesting that the animal pharmaceutical ... the first antibody drugs for pets approved by the ...
- Animal Health Giant Zoetis Stock Crumbles: Possible Side Effect Of Its Pet Arthritis Pain Drugs Sickened Dogs, Catson April 12, 2024 at 4:31 am
Zoetis' pain drugs for cats and dogs are under scrutiny as some pet owners link them to adverse effects and even deaths among their pets. But Zoetis said that these side effects represent a ...
- Medications, Holistic Options, & Home Remedies for Dog Painon February 8, 2024 at 1:15 pm
In dogs with other medical problems, steroid medications may be contraindicated or could cause ... There's always a potential health risk associated with using any pharmaceutical or herbal remedies.
via Bing News